As of now, there has been no formal FDA rule broadly removing a defined group of peptides from Category 2
Higher Experimental Research Range 3mg daily 9 insulin units Investigated in more intensive regenerative or tissue-related research models
Fat Loss and Improved Metabolism: The peptides enhance metabolism, leading to fat reduction, particularly in stubborn areas, which improves body composition and supports weight loss
However, considering the role of oxidative stress in DPN pathology, as well as identified mechanisms by which ALA may alleviate DPN symptoms, it would seem reasonable to assume that regular intake of ALA (e.g., 300 600 mg/d) may offer some protection against developing DPN symptoms, even when used as a monotherapy
doi: 10.3389/fonc.2026.1680441 Received 06 August 2025 Revised 20 January 2026 Accepted 20 January 2026 Published 03 February 2026 Volume 16 - 2026 Edited by Arumugam Jayakumar, University of Texas MD Anderson Cancer Center, United States Reviewed by Enrico Martin, University Medical Center Utrecht, Netherlands Fei Song, Affiliated Hospital of Nantong University, China Updates Copyright 2026 Zhu, Shen, Yang, Han, Li, Xie, Tan, Lu, Ji and Zhang
10.2174/157340708786305934 39 FengT.WeiY.LeeR